The TRAIL to cancer therapy: Hindrances and potential solutions
Author:
Funder
Fundamental Research Grant Scheme
Ministry of Education Malaysia
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference193 articles.
1. A mechanism of resistance to antibody-targeted immune attack;Aldeghaither;Cancer Immunol. Res.,2019
2. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells;Allensworth;Mol. Cancer Ther.,2012
3. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy;Almasan;Cytokine Growth Factor Rev.,2003
4. Targeting death and decoy receptors of the tumour-necrosis factor superfamily;Ashkenazi;Nat. Rev. Cancer,2002
5. Targeting the extrinsic apoptosis pathway in cancer;Ashkenazi;Cytokine Growth Factor Rev.,2008
Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies;Advanced Materials;2024-09-12
2. Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma;Cell Reports Medicine;2024-08
3. Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets;MedComm;2024-08
4. Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia;Journal of Experimental & Clinical Cancer Research;2024-06-22
5. Neuroprotective effects of anti-TRAIL-ICG nanoagent and its multimodal imaging evaluation in cerebral ischemia-reperfusion injury;Materials Today Bio;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3